https://orcid.org/0000-0003-1902-4734
Figures
Abstract
Introduction
While overdoses comprise the majority of opioid research, the comprehensive impact of the opioid crisis on emergency departments (EDs) and paramedic services has not been reported. We examined temporal changes in population-adjusted incidence rates of ED visits and paramedic transports due to opioid-related conditions.
Materials and methods
We conducted a population-based cohort study of all ED visits in the National Ambulatory Care Reporting System from January 1, 2009 to December 31, 2019 in Ontario, Canada. We included all patients with a primary diagnosis naming opioids as the underlying cause for the visit, without any other drugs or substances. We clustered geographic regions using Local Health Integration Network boundaries. Descriptive statistics, incidence rate ratios (IRR) and 95% confidence intervals (CIs) were calculated to analyze population-adjusted temporal changes.
Results
Overall, 86,403 ED visits were included in our study. Incidence of opioid-related ED visits increased by 165% in the study timeframe, with paramedic transported patients increasing by 429%. Per 100,000 residents, annual ED visits increased from 40.4 to 97.2, and paramedic transported patients from 12.1 to 67.9. The proportion of opioid-related ED visits transported by paramedics increased from 35.0% to 69.9%. The medical acuity of opioid-related ED visits increased throughout the years (IRR 6.8. 95% CI 5.9–7.7), though the proportion of discharges remained constant (~75%). The largest increases in ED visits and paramedic transports were concentrated to urbanized regions.
Discussion
Opioid-related ED visits and paramedic transports increased substantially between 2009 and 2019. The proportion of ED visits transported by paramedics doubled. Our findings could provide valuable support to health stakeholders in implementing timely strategies aimed at safely reducing opioid-related ED visits. The increased use of paramedics followed by high rates of ED discharge calls for exploration of alternative care models within paramedic systems, such as direct transport to specialized substance abuse centres.
Citation: Strum RP, Mondoux S, Mowbray FI, Miller P, Worster A, Ferron R, et al. (2023) Quantifying the escalating impact of paramedic transported emergency department visits for opioid-related conditions in Ontario, Canada: A population-based cohort study. PLoS ONE 18(9): e0291194. https://doi.org/10.1371/journal.pone.0291194
Editor: Jean Baptiste Lascarrou, CHU Nantes, FRANCE
Received: February 15, 2023; Accepted: August 24, 2023; Published: September 8, 2023
Copyright: © 2023 Strum et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting information files.
Funding: The authors received no specific funding for this work.
Competing interests: The authors have declared that no competing interests exist.
Introduction
The opioid crisis continues to be a public health challenge for Canada. In recent years more than eight people a day die of opioid-related poisonings in Canada [1, 2]. Despite considerable public health interventions to guard against opioid abuse and overdose, the national rates of mortality and hospital admissions continue to rise [3]. The root cause of Canada’s opioid crisis is complex and dependent on several factors, including increased prescription rates of long-acting oxycodone, prescription of opioids in high doses, and increased potency of illicit opioid drugs, mostly fentanyl and oxycodone [4–6]. This combination has cultivated an international healthcare opioid crisis in the past decade.
Between 2015 and 2017, Ontario reported a sharp increase in hospital visits and admissions related to opioids, representing a new wave of the opioid crisis in the province [7]. Although specific subgroups of opioid-related emergency department (ED) visits, such as overdoses and deaths, have been extensively studied, there is a lack of comprehensive understanding regarding the broader clinical impact of opioids on EDs and the overall health care system, such as mental health disorders due to opioids and opioid withdrawal syndromes. Furthermore, the magnitude of the effect of the opioid crisis on paramedic services, and clinical characteristics of ED transported patients, is unknown. No comprehensive research reports how ED and paramedic service utilization have changed during the opioid crisis in Ontario in the past decade that adjust for population-growth. As the prevalence of opioid disorders and overdoses continue to rise, it is important to quantify the full magnitude of the opioid epidemic impact on the healthcare system. Understanding the complete extent of this crisis on EDs and paramedic services could inform the urgency with which alternative interventions should be implemented to improve patient centred care for people who use opioids.
Our objective was to describe and quantify incidence changes of ED visits and paramedic transported visits due to opioid-related conditions in Ontario, Canada. We examined trends within the cohort for age, acuity, geographic location and year of visit, after adjusting for population growth.
Materials and methods
Study design
We conducted a population-based retrospective cohort study using administrative ED records from the National Ambulatory Care Reporting System (NACRS) database. We adhered to the Reporting of Studies Conducted Using Observational Routinely-Collected Health Data (RECORD) statement for the reporting of results [8].
Population and setting
All patients who were triaged in an Ontario ED between January 1, 2009 to December 31, 2019 were eligible for inclusion. We included all ED visits that had a primary diagnosis of an opioid-related condition as the reason for visit, as assigned by the ED physician. To reduce contamination and isolate visits specific to opioids, main diagnoses that included opioids among other illicit drugs were excluded. This study timeframe represents the most recently available decade prior to the COVID-19 pandemic, reducing any time-specific potential confounders likely to influence health outcomes and health service beyond 2019.
Data source
We extracted data from the NACRS database, a hospital and community-based ambulatory care administrative database that collects data for every patient’s ED visit at the time of service use in Ontario [9]. NACRS is housed within the Institute for Clinical Evaluative Sciences (ICES), a non-profit, independent corporation that supports the study of health service and outcomes at a population-level in Ontario. Data concerning Ontario’s population as a province and for each region were extracted from the Registered Persons Database (RPDB) at ICES. RPDB is a repository of all persons registered in Ontario under the Ontario Health Insurance Plan (OHIP) and eligible for universal healthcare services. These databases are routinely checked for quality and accuracy [10]. We identified the study population from the NACRS population database; we did not use any data cleaning methods as NACRS data are recorded using structured codification.
Variables and measurement
We identified the study population using the International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) codification system, as recorded in the main diagnostic category of the ED visit [11]. S1 Table shows the individual ICD-10 codes used to identify opioid-related ED visits in this study; individual patient-level data were aggregated to examine a complete ED visitation depiction of annual opioid-related visits. Patient age was originally extracted as twenty-two categorical levels due to personal health information privacy restrictions. The Canadian Triage and Acuity Scale (CTAS) was used to operationalize triage of patients at entry to ED, assigned by the ED triage nurse. CTAS is an ordinal scale that ranges from one to five, with a score of one indicating the highest acuity (resuscitation) and five the lowest acuity (non-urgent) [12]. Regionalization of Ontario was determined using the location of the ED within fourteen Local Health Integration Network (LHIN) boundaries. LHIN boundaries divide Ontario into fourteen smaller geographic sections, and are responsible for the planning and funding of hospital services within their geographic region.
Statistical analysis
We reported descriptive statistics using frequencies and proportions. We calculated incidence rates per 100,000 residents of the population for each year. We computed incidence rate ratios (IRR) with using 95% confidence intervals (CIs) to adjust for population growth as a predictor of ED visitation increases for opioid-related conditions [13]. Data were managed and analyzed in R (v. 3.6) [14]. We reported missing data directly and handled using complete-case analysis.
Ethics approval
ICES’s collection and use of NACRS secondary ambulatory data is authorized under Section 45 of Ontario’s Personal Health Information Protection Act (PHIPA) as a prescribed entity, which is exempt from review by a Research Ethics Board [15, 16]. The use of the data in this study is authorized under section 45 and approved by ICES’s Privacy and Legal Office.
Results
Overall, 86,403 ED visits between January 1, 2009 and December 31, 2019 were included in the study; no data were excluded or missing. Table 1 shows annual incidence changes of ED visits due to opioid-related conditions. Over the 11-year study period, total ED visits increased by 165% (8,741), with paramedic transported patients increasing by 429% (7,956). Opioid-related ED visits increased by 24 visits per day (14.5 to 38.5), and paramedic transports increased by 21.8 (5.1 to 26.9) per day. The proportion of ED visits transported by paramedics doubled from 35.0% to 69.9%. Adjusting for population growth, ED visits increased by 56.9 per 100,000 residents, constituting an IRR of 2.4 (95% CI 2.3–2.5). Paramedic transports increased by 53.8 per 100,000 residents, yielding an IRR of 4.8 (95% CI 4.6–5.0). A significant surge was observed in years 2016 and 2017 for both ED visits (IRR 1.2, 95% CI 1.2–1.2; IRR 1.4 95% CI 1.4–1.5 respectively) and paramedic transports (IRR 1.3, 95% CI 1.2–1.3; IRR 1.7, 85% CI 1.7–1.8 respectively).
Table 2 shows the distribution of ED visits based on type of opioid problem over the study years, the largest being poisoning (46% all ED visits, 68% paramedic transported), and mental and behavioural disorders due to opioid withdrawal (28% all ED visits, 14% paramedic transported).
Fig 1 displays surges in opioid-related ED visits across all age groups between 10 and 60 years of age during the study years, specifically during 2016 and 2017. The annual incidence of paramedic transported patients remained relatively constant between 2009 to 2015, but experienced an exponential increase thereafter. Ages between 0 and 9 years, and 71 to 105 years, are not shown as incidence were relatively scant.
Table 3 shows descriptive statistics of ED visits of 2009 and 2019. In these years, the majority of patients shifted from female to male. Increases in the most emergent triage acuity scores were observed (CTAS 1 to 3), while lower acuity scores decreased (CTAS 4 and 5). ED visit disposition remained consistent across these years, with over three quarters of visits discharged without any hospital admission (76.2% in 2009, 75.6% in 2019). The proportion of patients returning to the ED within 30 days increased slightly for all ED visits and those transported by paramedics over the study period (33.1% to 36.3%, 30.2% to 35.3%, respectively).
Fig 2 shows ranked IRRs across geographic locations for opioid-related ED visits in a comparison between 2009 and 2019. Population-adjusted rates of ED visits and paramedic transported visits increases across all LHIN’s. For ED visits, Toronto Central (IRR 4.9, 95% CI 4.4–5.5), Mississauga Halton (IRR 4.3, 95% CI 3.5–5.2) and Hamilton Niagara Haldimand Brant (IRR 4.0, 95% CI 3.6–4.4) had the largest increases of population-adjusted annual incidence. Of paramedic transported ED visits, the largest rates were observed in LHINs Mississauga Halton (IRR 9.5, 95% CI 6.9–13.1), Toronto Central (IRR 8.7, 95% CI 7.5–10.3) and Hamilton Niagara Haldimand Brant (IRR 7.0, 95% CI 6.1–8.1).
Discussion
Opioid-related ED visits grew substantially over the decade preceding the COVID-19 pandemic, specifically 2016 and 2017. Incident rates of paramedic transports doubled, becoming the primary mode of transport to the ED. Opioid-related visits became more clinically severe, though the overall rates of ED discharges remained consistent. After adjusting for population growth, opioid-related ED visits grew throughout all of Ontario, though considerable growth was found in more urbanized regions.
Our findings align with previous national and international literature, highlighting the substantial growth of opioid poisoning and opioid-related ED visits during 2016 and 2017 [2, 17, 18]. However, prior studies do not account for population-growth, nor do they examine the implications on paramedic systems that respond to 9-1-1 emergencies. Research suggests the growth of opioid poisoning and opioid-related ED visits during 2014 and 2015 rose to 21 per 100,000 across Ontario, a result consistent with our findings prior to the 2016 and 2017 visit spikes. The drastic increase in visits between 2016 and 2017 we determined are underreported in the literature for Canada. International findings parallel our results, citing a 29.7% increase across the United States of America over this timeframe when ED visits increased markedly [19]. Consistent with previous literature, our study found young adults (19 to 35 years) had the largest increase of ED visits and aligns with the largest age demographic that die from opioid overdoses and poisonings [2, 18–20]. Notably, minimal research describes the changes in acuity scores for opioid-related visits, and quantifiable estimates of the impact of these visits on paramedic systems are lacking in the literature.
Prescription of high-dose opioids is one potential explanation for our observation of increased opioid-related ED visits. A study of opioid dispensing in 2011 found Ontario had the largest high-dose opioid dispensing rates amongst all Canadian provinces, which we postulate continued in the years following [21]. Another explanation is the surge of illicit fentanyl, fentanyl analogues and synthetic opioid use in Canada in 2016, as evidenced by illegal drug seizures and death investigations [22]. Street derivatives of opioids became more prevalent and potent in these years, notably with carfentanil, an opioid that is 100 times more potent than fentanyl [22]. More often illicit street drugs are combined with fentanyl, leading to increased risk of overdose, addiction and death, which we observed in our study with higher triage acuity scores. In British Columbia, 68% of illicit drug deaths involved fentanyl in 2016, and increased to 83% in 2017 [23]. We hypothesize that the short half-life of opioids, increased availability of reversal agents (i.e. naloxone), more accessible to community treatment options (i.e. addictions clinics, specialized case managers) and low obligation for psychiatric assessment of acute drug intoxications mitigate the risk for discharge of recurrent opioid users and contribute to the high rate of ED discharge. We propose the large surge in paramedic transports may be attributed to heightened public awareness campaigns regarding opioid use and when to call 9-1-1, as well as understanding paramedics are equipped with reversal agents.
Our evaluation of temporal changes of ED and paramedic utilization for opioid-related conditions can support interventions that improve patient-centered care while reducing use of scarce ED services [24]. We determined that growth in opioid-related ED visits concentrated to urbanized regions and younger adults could not be attributed to population growth. Identification and correction of barriers to community and complementary opioid services should be a point of focus for these cohorts to reduce the burden of opioids on the healthcare system. Such barriers include limited evening and overnight care access and poor accessibility to complementary psychotherapy for opioid use disorders [25].
Though we found an increase in medical acuity from 2009 to 2019, we did not observe a corresponding increase in the proportion of ED patients admitted to hospital or a significant increase in returned ED visit within 30 days. This is an important finding, suggesting that EDs are capable of managing and treating the vast majority of opioid-related patient conditions. We postulate the substantial spike in paramedic transports followed by high rates of ED discharge calls for exploration of equivalent or superior care alternatives in paramedic systems. Alternative paramedic care models could include transport of patients with opioid-related conditions to specific substance abuse outpatient centres that specialize in opioid addiction, dependence and mental health treatment programs [26]. Community paramedicine is a growing field of paramedicine that can provide community care and monitoring for certain carefully selected patient cohorts [27]. Commissioning community paramedics to monitor and provide specialized care for opioid users could be a feasible and proactive solution to reduce 9-1-1 calls and transports due to opioid-related disorders. Lastly, paramedics could cultivate unique specialized response units that have extended training in substance use, opioids and mental health crises to respond specifically to opioid-related 9-1-1 calls and provide chronic therapeutics in the community, such as buprenorphine with naloxone or derivatives of buprenorphine [28].
To our knowledge, this is the first comprehensive study that evaluated changes in annual incidence of ED visits and paramedic transports for patients with opioid-related conditions in Canada. Our findings are likely generalizable to other Canadian provinces and countries where reports of an opioid crisis have been reported, and where paramedic systems are similarly organized. Interventions are needed to improve management of opioid-related conditions and reduce the burden of opioids on overstrained EDs. Examination of incidence changes during the COVID-19 pandemic is needed to quantify healthcare utilization sought by patients with opioid-related conditions, and understand trends to prepare healthcare systems for the future. Lastly, it is important to note that our study did not fully capture the impact of the opioid crisis on paramedic services, as we were unable to account for paramedic responses that did not result in ED transport. This aspect presents an avenue for further research, and could include data features not captured in the ED such as quantity of 911 calls for opioid-related conditions, rationale for declining ED transport, opioid-related condition of non-transported patients and response time metrics for patients that sought paramedic care.
Limitations
Due to the nature of retrospective observational studies, the specific cause of the surge in ED visits could not be determined. Overall paramedic utilization is underreported in this study; instances where paramedics attended to patients but ED transport was refused are not captured in this cohort. Finally, opioid-related ED visits that were coded in NACRS using heterogeneous codification that included other non-opioid drugs or alcohol could not be included to avoid bias and an overestimation of opioid-related visits. Thus, our totals of ED visits related to opioids are underestimated and conservative with regard to the true magnitude of the opioid-related crisis. A plausible explanation of our findings is physicians became more precise in their codification of visits (i.e. specifying opioids, instead of generalized terms such as ‘drug use’). We argue this is not the cause, as generalized drug codes remain consistent over the study years and did not decrease when opioid-related condition codes increased.
Conclusion
ED visits due to opioid-related conditions increased by 165% between 2009 to 2019. The related growth in visits transported by paramedics was markedly high at 429% over the same time period. These results can inform public health stakeholders of the magnitude and one cause of growth in ED visits, and support strategies to reduce opioid-related ED visits. The preponderance of patients are discharged back to the community, which may support paramedic care models that reduce transports to EDs by providing acute and chronic therapy onsite without transport, or transporting these patients directly to specialized substance abuse centres instead of overcrowded EDs.
Supporting information
S1 Table. ICD-10 codification.
ICD-10 codification of the cohort of opioid-related emergency department visits in the National Ambulatory Care Reporting System from January 1, 2009 to December 31, 2019.
https://doi.org/10.1371/journal.pone.0291194.s001
(DOCX)
S1 Checklist. The RECORD statement—Checklist of items, extended from the STROBE statement, that should be reported in observational studies using routinely collected health data.
https://doi.org/10.1371/journal.pone.0291194.s002
(DOCX)
References
- 1. Fischer B, Pang M, Tyndall M. The opioid death crisis in Canada: crucial lessons for public health. Lancet Public Health [Internet]. 2019 Feb 1 [cited 2022 Dec 1];4(2):e81–2. Available from: https://www.thelancet.com/journals/lancet/article/PIIS2468-2667(18)30232-9/fulltext pmid:30579840
- 2. Lisa B, Jessica H. Evidence synthesis—The opioid crisis in Canada: a national perspective. Health Promot Chronic Dis Prev Can Res Policy Pract [Internet]. 2018 Jun [cited 2022 Dec 1];38(6):224–33. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034966/
- 3. Wood E. Strategies for Reducing Opioid-Overdose Deaths—Lessons from Canada. N Engl J Med. 2018 Apr 26;378(17):1565–7. pmid:29694813
- 4. Dhalla IA, Mamdani MM, Sivilotti MLA, Kopp A, Qureshi O, Juurlink DN. Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ [Internet]. 2009 Dec 8 [cited 2022 Dec 1];181(12):891–6. Available from: https://www.cmaj.ca/content/181/12/891 pmid:19969578
- 5. Gomes T, Juurlink D, Moineddin R, Gozdyra P, Dhalla I, Mamdani MP and M. Geographical Variation in Opioid Prescribing and Opioid-Related Mortality in Ontario. Healthc Q [Internet]. 2011 Jan 27 [cited 2022 Dec 1];14(1). Available from: https://www.longwoods.com/content/22153/healthcare-quarterly/geographical-variation-in-opioid-prescribing-and-opioid-related-mortality-in-ontario pmid:21301233
- 6. Collier R. Street versions of opioids more potent and dangerous. CMAJ Can Med Assoc J [Internet]. 2013 Sep 3 [cited 2022 Dec 1];185(12):1027. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3761004/ pmid:23836854
- 7. Shannon O, Vera G, Krista L. At-a-glance—Hospitalizations and emergency department visits due to opioid poisoning in Canada. Health Promot Chronic Dis Prev Can Res Policy Pract [Internet]. 2018 Jun [cited 2022 Dec 1];38(6):244–7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034974/
- 8. Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement. PLOS Med [Internet]. 2015 Oct 6 [cited 2022 Feb 15];12(10):e1001885. Available from: https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001885 pmid:26440803
- 9. Li G, Lau JT, McCarthy ML, Schull MJ, Vermeulen M, Kelen GD. Emergency Department Utilization in the United States and Ontario, Canada. Acad Emerg Med [Internet]. 2007 [cited 2020 Dec 4];14(6):582–4. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1197/j.aem.2007.02.030 pmid:17470903
- 10.
Data and Information Quality [Internet]. [cited 2023 Jan 5]. https://www.cihi.ca/en/submit-data-and-view-standards/data-and-information-quality/previous-years?field_acronyms_databases_target_id=All&title=&page=1
- 11.
Canadian Institute for Health Information. Canadian Coding Standards for Version 2018 ICD-10-CA and CCI. CIHI; 2018.
- 12. Bullard MJ, Unger B, Spence J, Grafstein E, the CTAS National Working Group. Revisions to the Canadian Emergency Department Triage and Acuity Scale (CTAS) adult guidelines. CJEM [Internet]. 2008 Mar [cited 2020 Dec 5];10(02):136–42. Available from: https://www.cambridge.org/core/product/identifier/S1481803500009854/type/journal_article
- 13. Martin DO, Austin H. Exact Estimates for a Rate Ratio. Epidemiology [Internet]. 1996 [cited 2022 Jan 23];7(1):29–33. Available from: https://www.jstor.org/stable/3702753 pmid:8664397
- 14.
Wickham H, François R, Henry L, Müller K, RStudio. dplyr: A Grammar of Data Manipulation [Internet]. 2021 [cited 2022 Jan 23]. https://CRAN.R-project.org/package=dplyr
- 15.
Government of Ontario. Personal Health Information Protection Act, 2004, S.O. 2004, c. 3, Sched. A [Internet]. Jul 24, 2014. https://www.ontario.ca/laws/statute/04p03#BK63
- 16.
Government of Ontario. Ontario Regulation 329/04: General, Personal Health Information Protection Act [Internet]. Sect. 18. Prescribed entitites for the purposes of s. 45 (1) of the Act 02, 2021. https://www.ontario.ca/laws/regulation/040329#BK19
- 17. Langabeer JR, Stotts AL, Bobrow BJ, Wang HE, Chambers KA, Yatsco AJ, et al. Prevalence and charges of opioid-related visits to U.S. emergency departments. Drug Alcohol Depend. 2021 Apr 1;221:108568.
- 18.
Canadian Institute for Health Information, Centre on Substance Abuse. Hospitalizations and Emergency Department Visits Due to Opioid Poisoning in Canada. 2016.
- 19. Vivolo-Kantor AM. Vital Signs: Trends in Emergency Department Visits for Suspected Opioid Overdoses—United States, July 2016–September 2017. MMWR Morb Mortal Wkly Rep [Internet]. 2018 [cited 2022 Dec 7];67. Available from: https://www.cdc.gov/mmwr/volumes/67/wr/mm6709e1.htm pmid:29518069
- 20. Choi S, Biello KB, Bazzi AR, Drainoni ML. Age differences in emergency department utilization and repeat visits among patients with opioid use disorder at an urban safety-net hospital: A focus on young adults. Drug Alcohol Depend [Internet]. 2019 Jul 1 [cited 2022 Dec 7];200:14–8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588461/ pmid:31071494
- 21. Gomes T, Mamdani MM, Paterson JM, Dhalla IA, Juurlink DN. Trends in high-dose opioid prescribing in Canada. Can Fam Physician [Internet]. 2014 Sep 1 [cited 2022 Dec 7];60(9):826–32. Available from: https://www.cfp.ca/content/60/9/826 pmid:25217680
- 22.
Health Canada. Drug Analysis Service: Summary report of samples analysed 2016 [Internet]. 2017. https://www.canada.ca/en/health-canada/services/health-concerns/controlled-substances-precursor-chemicals/drug-analysis-service/2016-drug-analysis-service-summary-report-samples-analysed.html
- 23.
Special Advisory Committee on the Epidemic of Opioid Overdoses PHA of C. National report: Apparent opioid-related deaths in Canada (January 2016 to June 2017) [Internet]. 2017. https://www.canada.ca/en/public-health/services/publications/healthy-living/apparent-opioid-related-deaths-report-2016-2017-december.html
- 24. Strum RP, Drennan IR, Mowbray FI, Mondoux S, Worster A, Babe G, et al. Increased demand for paramedic transports to the emergency department in Ontario, Canada: a population-level descriptive study from 2010 to 2019. Can J Emerg Med [Internet]. 2022 Aug 19 [cited 2022 Aug 24]; Available from: pmid:35984572
- 25. Pijl EM, Alraja A, Duff E, Cooke C, Dash S, Nayak N, et al. Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: an integrative review. Subst Abuse Treat Prev Policy [Internet]. 2022 Aug 26 [cited 2022 Dec 13];17(1):62. Available from: pmid:36028837
- 26. Strum RP, Mowbray FI, Mondoux SE, Costa AP. Evaluating emergency department transfers from urgent care centres: insights for paramedic integration with subacute healthcare. BMJ Open Qual [Internet]. 2023 Mar 1 [cited 2023 Jul 14];12(1):e002160. Available from: https://bmjopenquality.bmj.com/content/12/1/e002160 pmid:36894178
- 27. Leyenaar M, McLeod B, Penhearow S, Strum R, Brydges M, Brousseau A, et al. P085: What do community paramedics assess? An environmental scan and content analysis of patient assessment in community paramedicine. Can J Emerg Med [Internet]. 2019 May [cited 2021 Aug 27];21(S1):S94–S94. Available from: https://www.cambridge.org/core/journals/canadian-journal-of-emergency-medicine/article/p085-what-do-community-paramedics-assess-an-environmental-scan-and-content-analysis-of-patient-assessment-in-community-paramedicine/6641DB0186C5B4C71DAC212C13B31B6F
- 28. Hern HG, Lara V, Goldstein D, Kalmin M, Kidane S, Shoptaw S, et al. Prehospital Buprenorphine Treatment for Opioid Use Disorder by Paramedics: First Year Results of the EMS Buprenorphine Use Pilot. Prehosp Emerg Care. 2022 May 13;1–9. pmid:35420925